Can pretreatment serum calcium level predict the efficacy of methotrexate in the treatment of severe plaque psoriasis?

@article{Zhai2015CanPS,
  title={Can pretreatment serum calcium level predict the efficacy of methotrexate in the treatment of severe plaque psoriasis?},
  author={Z. Zhai and Lingui Chen and Huan Yang and Jun Yan and Chunyou Wang and Jinxin Yang and Wenying Liu and Zhu Shen},
  journal={Journal of the American Academy of Dermatology},
  year={2015},
  volume={73 6},
  pages={
          991-7.e3
        }
}
BACKGROUND The efficacy of methotrexate (MTX) varies in the treatment of psoriasis. OBJECTIVE We sought to identify an indicator from routine pretreatment tests to predict MTX efficacy in the treatment of psoriasis. METHODS In a retrospective analysis of 77 psoriatic patients, the correlation between MTX efficacy and pretreatment routine test results was analyzed with Spearman correlation. The potential risks were further evaluated with a linear regression model. Receiver operating… Expand

References

SHOWING 1-10 OF 28 REFERENCES
Studying the calcium serum level in patients suffering from psoriasis.
A 52-week trial comparing briakinumab with methotrexate in patients with psoriasis.
Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis.
Advances in the treatment of moderate-to-severe plaque psoriasis.
  • R. Herrier
  • Medicine
  • American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
  • 2011
Methotrexate in dermatology
Outcomes of methotrexate therapy for psoriasis and relationship to genetic polymorphisms
...
1
2
3
...